Dr. Jonathan S. Weiss, MD
Dermatology (Dermatology Physician)
- Medicare participating
At a glance
- Medical school
- University of Michigan Medical School (1984)
- Years since graduation
- 42
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 1,344
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1984Medical school: University of Michigan Medical School
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
GA license 029820
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Gwinnett Dermatology, PC D/b/a Georgia Dermatology PArtners (19 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,344
- Services billed
- 26,169
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 3,051 | 500 |
| Established patient office or other outpatient visit, 20-29 minutes | 1,486 | 976 |
| Destruction of precancer skin growth, 1 growth | 823 | 624 |
| Biopsy of related skin growth, first growth | 404 | 344 |
| Destruction of skin growth, 1-14 growths | 204 | 189 |
| New patient office or other outpatient visit, 30-44 minutes | 168 | 168 |
| Established patient office or other outpatient visit, 30-39 minutes | 158 | 106 |
| Biopsy of related skin growth, each additional growth | 143 | 86 |
| Established patient office or other outpatient visit, 10-19 minutes | 68 | 64 |
| Insertion of needle into vein for collection of blood sample | 55 | 40 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 25 companies reported 301 payments worth $126,190 in total to this clinician.
| Galderma Laboratories, L.P. | $41,210 |
|---|---|
| AbbVie Inc. | $22,985 |
| Botanix Sb Inc | $12,855 |
| Genzyme Corporation | $12,213 |
| Pfizer Inc. | $10,987 |
| Regeneron Healthcare Solutions, Inc. | $9,152 |
| UCB, Inc. | $5,065 |
| Leo Pharma Inc. | $3,881 |
| Compensation for services other than consulting (speaking, faculty) | $89,951 |
|---|---|
| Consulting Fee | $26,053 |
| Food and Beverage | $8,317 |
| Travel and Lodging | $1,765 |
| Education | $105 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Pfizer Inc. May 22, 2025 | Consulting Fee LITFULO · IMMUNOLOGY | $9,595 |
| Regeneron Healthcare Solutions, Inc. Jun 24, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $6,924 |
| Genzyme Corporation Sep 10, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $6,208 |
| Galderma Laboratories, L.P. Jul 23, 2025 | Compensation for services other than consulting (speaking, faculty) NEMLUVIO · DERMATITIS | $5,400 |
| Galderma Laboratories, L.P. Oct 24, 2025 | Compensation for services other than consulting (speaking, faculty) NEMLUVIO · DERMATITIS | $5,400 |
| Galderma Laboratories, L.P. Dec 1, 2025 | Compensation for services other than consulting (speaking, faculty) NEMLUVIO · DERMATITIS | $5,400 |
| Genzyme Corporation Oct 29, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $5,253 |
| Galderma Laboratories, L.P. Jan 29, 2025 | Compensation for services other than consulting (speaking, faculty) NEMLUVIO · DERMATITIS | $3,600 |
| Galderma Laboratories, L.P. Aug 15, 2025 | Compensation for services other than consulting (speaking, faculty) NEMLUVIO · DERMATITIS | $3,600 |
| Galderma Laboratories, L.P. Nov 7, 2025 | Compensation for services other than consulting (speaking, faculty) NEMLUVIO · DERMATITIS | $3,600 |
All 46 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Galderma Laboratories, L.P. Dec 1, 2025 | Compensation for services other than consulting (speaking, faculty) NEMLUVIO · DERMATITIS | $5,400 |
| AbbVie Inc. Dec 1, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $1,725 |
| Incyte Corporation Nov 13, 2025 | Consulting Fee | $3,260 |
| Galderma Laboratories, L.P. Nov 7, 2025 | Compensation for services other than consulting (speaking, faculty) NEMLUVIO · DERMATITIS | $3,600 |
| Galderma Laboratories, L.P. Nov 7, 2025 | Compensation for services other than consulting (speaking, faculty) NEMLUVIO · DERMATITIS | $3,600 |
| Galderma Laboratories, L.P. Oct 30, 2025 | Travel and Lodging NEMLUVIO · DERMATITIS · travel to PEACHTREE CORNERS, GA · in-kind | $30.00 |
| Genzyme Corporation Oct 29, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $5,253 |
| Galderma Laboratories, L.P. Oct 28, 2025 | Travel and Lodging NEMLUVIO · DERMATITIS · travel to WATKINSVILLE, GA · in-kind | $77.00 |
| Galderma Laboratories, L.P. Oct 24, 2025 | Compensation for services other than consulting (speaking, faculty) NEMLUVIO · DERMATITIS | $5,400 |
| AbbVie Inc. Oct 14, 2025 | Travel and Lodging RINVOQ · IMMUNOLOGY · travel to CUMMING, GA · in-kind | $51.80 |
| Galderma Laboratories, L.P. Oct 9, 2025 | Consulting Fee | $3,160 |
| AbbVie Inc. Oct 6, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $2,875 |
| Genzyme Corporation Sep 10, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $6,208 |
| Galderma Laboratories, L.P. Aug 18, 2025 | Compensation for services other than consulting (speaking, faculty) AKLIEF · ACNE | $600 |
| Galderma Laboratories, L.P. Aug 15, 2025 | Compensation for services other than consulting (speaking, faculty) NEMLUVIO · DERMATITIS | $3,600 |
| AbbVie Inc. Aug 14, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $2,875 |
| AbbVie Inc. Aug 14, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $2,875 |
| AbbVie Inc. Aug 14, 2025 | Travel and Lodging RINVOQ · IMMUNOLOGY · travel to CUMMING, GA · in-kind | $54.60 |
| AbbVie Inc. Aug 12, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $2,875 |
| UCB, Inc. Aug 5, 2025 | Consulting Fee Bimzelx · Immunology | $2,250 |
| Galderma Laboratories, L.P. Aug 4, 2025 | Compensation for services other than consulting (speaking, faculty) NEMLUVIO · DERMATITIS | $600 |
| Galderma Laboratories, L.P. Jul 28, 2025 | Travel and Lodging NEMLUVIO · DERMATITIS · travel to ATHENS, GA · in-kind | $83.72 |
| Regeneron Healthcare Solutions, Inc. Jul 25, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $1,671 |
| Galderma Laboratories, L.P. Jul 23, 2025 | Compensation for services other than consulting (speaking, faculty) NEMLUVIO · DERMATITIS | $5,400 |
| Botanix Sb Inc Jul 21, 2025 | Compensation for services other than consulting (speaking, faculty) SOFDRA · DERMATOLOGY | $3,500 |
| Botanix Sb Inc Jul 21, 2025 | Travel and Lodging SOFDRA · DERMATOLOGY · travel to ALPHARETTA, GA | $36.40 |
| Sun Pharmaceutical Industries Inc. Jul 16, 2025 | Education in-kind | $94.99 |
| Botanix Sb Inc Jul 1, 2025 | Compensation for services other than consulting (speaking, faculty) SOFDRA · DERMATOLOGY | $3,500 |
| Regeneron Healthcare Solutions, Inc. Jun 24, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $6,924 |
| Leo Pharma Inc. Jun 12, 2025 | Consulting Fee | $3,168 |
| AbbVie Inc. Jun 10, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $2,875 |
| Botanix Sb Inc Jun 5, 2025 | Compensation for services other than consulting (speaking, faculty) SOFDRA · DERMATOLOGY | $3,500 |
| Galderma Laboratories, L.P. Jun 4, 2025 | Consulting Fee NEMLUVIO · DERMATITIS | $1,580 |
| Pfizer Inc. May 22, 2025 | Consulting Fee LITFULO · IMMUNOLOGY | $9,595 |
| Pfizer Inc. May 22, 2025 | Compensation for services other than consulting (speaking, faculty) LITFULO · IMMUNOLOGY | $1,045 |
| AbbVie Inc. May 12, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $2,875 |
| AbbVie Inc. Apr 22, 2025 | Education SKYRIZI · IMMUNOLOGY · in-kind | $9.65 |
| AbbVie Inc. Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $2,875 |
| Regeneron Healthcare Solutions, Inc. Apr 9, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to DETROIT, MI · in-kind | $452 |
| Botanix Sb Inc Mar 4, 2025 | Compensation for services other than consulting (speaking, faculty) SOFDRA · DERMATOLOGY | $2,000 |
| Galderma Laboratories, L.P. Jan 29, 2025 | Compensation for services other than consulting (speaking, faculty) NEMLUVIO · DERMATITIS | $3,600 |
| Galderma Laboratories, L.P. Jan 29, 2025 | Consulting Fee NEMLUVIO · DERMATITIS | $790 |
| Novartis Pharmaceuticals Corporation Jan 23, 2025 | Travel and Lodging travel to Orlando, FL · in-kind | $680 |
| Novartis Pharmaceuticals Corporation Jan 23, 2025 | Travel and Lodging travel to Orlando, FL · in-kind | $299 |
| Galderma Laboratories, L.P. Jan 15, 2025 | Compensation for services other than consulting (speaking, faculty) NEMLUVIO · DERMATITIS | $2,700 |
| UCB, Inc. Jan 7, 2025 | Consulting Fee Bimzelx · Immunology | $2,250 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 3 companies. The companies reported $98,274 in research payments for these studies, mostly to the institutions running them.
- Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp
Biofrontera Inc. · Completed · NCT05662202 - 24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-lab…
Novartis Pharmaceuticals Corporation - A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting
E.r. Squibb & Sons, L.l.c. · Completed · NCT05701995
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.